PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Advanced MRI technology detects changes in the brain after COVID-19

Advanced MRI technology detects changes in the brain after COVID-19
2023-12-11
(Press-News.org) Researchers at Linköping University, Sweden, have examined the brains of 16 patients previously hospitalised for COVID-19 with persisting symptoms. They have found differences in brain tissue structure between patients with persisting symptoms after COVID-19 and healthy people. Their findings, published in the journal Brain Communications, can bring insights into the underlying mechanisms of persisting neurological problems after COVID-19.

Several previous studies of persisting problems after COVID have involved MRI brain scanning. Although researchers have found differences compared with healthy brains, these differences are not specific to COVID-19.

“It can be frustrating for me as a doctor when I understand that the patients have problems, but I can’t find an explanation because there’s nothing in the MRI scan to explain it. To me, this underlines the importance of trying other examination technologies to understand what’s happening in the brain in patients with persisting symptoms after COVID-19,” says Ida Blystad, neuroradiologist in the Department of Radiology at Linköping University Hospital and researcher affiliated with the Department of Health, Medicine and Caring Sciences at Linköping University and the Centre for Medical Image Science and Visualization (CMIV).

In their current study, the researchers have therefore added a new type of MR imaging called advanced diffusion MRI. They were particularly interested in the brain’s white matter. This consists mainly of nerve axons and is very important for transporting signals between the different parts of the brain and the rest of the body.

“Diffusion MRI is a very sensitive technology that allows changes in how the nerve axons are organised to be detected. This is one of the reasons why we wanted to use diffusion MRI to study the effects of COVID-19 on the brain that other imaging technologies might not pick up,” says Deneb Boito, doctoral student at the Department of Biomedical Engineering at Linköping University.

To get an idea of what diffusion MRI is, we can imagine a big city at night. Car headlights and rear lights shine like red and white strings of pearls on the most trafficked roads. We cannot see the road itself, but we understand that it is there, as the cars can easily move about right there. Similarly, doctors and researchers can get an insight into how the brain is constructed on a microscopic level through diffusion MRI. This technology builds on the fact that there is water everywhere in the brain moving in the tissue according to the law of least resistance. Water molecules move more easily along the neural pathways. By measuring the movement of water molecules through the neural pathways, researchers can indirectly infer the structure of neural pathways, just as we can indirectly understand that there is a motorway where there are many cars driving.

Healthcare usages of diffusion MRI include diagnosing stroke and planning brain surgery. In their current study, the researchers used a more advanced version of diffusion MRI. They examined 16 men who had been hospitalised for severe COVID-19 and who are participating in the Linköping COVID-19 Study (LinCos) at the Department of Rehabilitation Medicine in Linköping. They still had persisting symptoms after seven months. This group was compared with a group of healthy individuals without post-COVID symptoms who had not been hospitalised for COVID. The participants’ brains were examined with both conventional MRI and diffusion MRI.

“The two groups differ when it comes to brain white matter structure. This can be one of the causes of the neurological problems experienced by the group that had suffered from severe COVID-19. It’s a result that’s in line with other studies that have shown changes to the brain’s white matter. However, having examined only a small group of patients, we are cautious about drawing any major conclusions. With this technology, we’re not measuring the function of the brain, but its microstructure. To me, these findings are a sign that we must investigate long-term effects of COVID-19 in the brain using more advanced MRI technology than conventional MRI,” says Ida Blystad.

There are several issues that the researchers want to study further. It appears, for instance, that white matter in different parts of the brain is affected in different ways, although it is too early to draw any conclusions as to what these differences mean. An upcoming study will investigate whether changes detected with diffusion MRI are in any way connected to brain activity, and how different parts of the brain communicate with each other through the brain white matter in patients suffering from post-COVID fatigue.

Another question is what happens over time. The MRI scan provides an image of the brain at that particular moment. As the participants were examined on one occasion only, it is not possible to know whether the differences between the two groups will disappear over time or whether they are permanent.

This research was funded by, among others, the Analytic Imaging Diagnostic Arena (AIDA), the ITEA/Vinnova project ASSIST, and the Wallenberg Center for Molecular Medicine at Linköping University.

Article: MRI with generalized diffusion encoding reveals damaged white matter in patients previously hospitalized for COVID-19 and with persisting symptoms at follow-up, (2023), Deneb Boito, Anders Eklund, Anders Tisell, Richard Levi, Evren Özarslan and Ida Blystad, Brain Communications, published online 22 October 2023, doi: 10.1093/braincomms/fcad284

First MRI article from the LinCos study: Brain MRI and neuropsychological findings at long-term follow-up after COVID-19 hospitalisation: an observational cohort study, Hellgren L, Birberg Thornberg U, Samuelsson K, Levi R, Divanoglou A, Blystad I, BMJ Open 2021 Oct 27;11(10):e055164. doi: 10.1136/bmjopen-2021-055164

END

[Attachments] See images for this press release:
Advanced MRI technology detects changes in the brain after COVID-19 Advanced MRI technology detects changes in the brain after COVID-19 2 Advanced MRI technology detects changes in the brain after COVID-19 3

ELSE PRESS RELEASES FROM THIS DATE:

New study reveals latest data on global burden of cardiovascular disease

2023-12-11
A world without cardiovascular disease (CVD) is possible, yet millions of lives are lost prematurely to heart disease each year, according to the new Global Burden of Disease (GBD) special report published today in the Journal of the American College of Cardiology. The report provides an update of health estimates for the global, regional and national burden and trends of CVD from 1990-2022 by analyzing the impact of cardiovascular conditions and risk factors across 21 global regions. Research from this study reflects an urgent need ...

Rail industry urged to consider safety risks of space weather

Rail industry urged to consider safety risks of space weather
2023-12-11
Train accidents could be caused by solar storms switching signalling from red to green according to new research examining the impact of space weather. Solar storms can trigger powerful magnetic disturbances on Earth, creating geomagnetically induced currents (GICs) which could potentially interfere with electricity transmission and distribution grids. A team led by PhD researcher Cameron Patterson and Professor Jim Wild from Lancaster University modelled how GICs flowed through the track circuits of AC electrified lines powered with overhead cables. Using two routes - the Preston to Lancaster section of the West ...

Technology not growing fast enough to decarbonize steel and cement industries by 2050

2023-12-11
Steel and cement are two materials that no society can do without. Their production comes with a significant carbon footprint, however. To meet zero-emission targets under the Paris Agreement, countries, cities, and industries are depending on new large-scale infrastructure for CO2 transport and storage, renewable electricity and green hydrogen. A new study by researchers at the National Institute for Environmental Studies, Japan, and the University of Cambridge, United Kingdom, shows that the current rate of deployment of this infrastructure is insufficient. The study ...

Landscape for AML patients evolving rapidly as research discoveries advance new treatments

Landscape for AML patients evolving rapidly as research discoveries advance new treatments
2023-12-11
MIAMI, FLORIDA (EMBARGOED UNTIL DEC. 10, 2023, AT 7:30 P.M. ET) – The treatment landscape for acute myeloid leukemia (AML) is evolving rapidly, as research discoveries at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and other academic cancer centers advance new, more effective therapies for this aggressive blood cancer.  “We’ve seen more progress during the past 10 years than the previous four decades combined,” said Justin M. Watts, M.D., Sylvester hematologist, associate professor of medicine, and Pap Corps Early Career ...

'Exceptional' results in phase III leukaemia trial

2023-12-11
University of Leeds news Embargo: 19:30 ET on Sunday 10 December 2023 / 00.30 GMT on Monday 11 December 2023 New personalised therapy improves survival for patients with CLL leukaemia Personalised treatment for the most common form of adult leukaemia helps patients survive for longer and stay in remission, a phase III trial has found. The trial, by the University of Leeds, has been identified as groundbreaking research by the New England Journal of Medicine and the 65th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego, where ...

Cell therapy appears safe and effective for lymphoma in remission

Cell therapy appears safe and effective for lymphoma in remission
2023-12-11
DOWNLOADABLE VIDEO HERE MIAMI, FLORIDA (EMBARGOED UNTIL SUNDAY, DEC. 10, 2023 AT 8:00 P.M. ET) – A study led by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine suggests that CAR-T immunotherapy remains a viable option for patients who have lymphoma that goes into remission before the cell therapy begins. While the study doesn’t answer the question of whether cell therapy in remission is the right choice, it does say that it’s not the wrong choice. “I ...

ASH: Novel combination therapy significantly reduces spleen volume in patients with myelofibrosis

2023-12-10
SAN DIEGO ― Combining the JAK inhibitor ruxolitinib with the BCL-xL inhibitor navitoclax was twice as effective in reducing enlarged spleens – a major indicator of clinical improvement – compared with standard-of-care ruxolitinib monotherapy for adult patients with intermediate or high-risk myelofibrosis, a rare bone marrow cancer, according to results of the Phase III TRANSFORM-1 trial reported by researchers from The University of Texas MD Anderson Cancer Center. Data from the global, randomized, placebo-controlled ...

ASH: Novel menin inhibitors show promise for patients with advanced acute myeloid leukemias

2023-12-09
SAN DIEGO ― Two clinical trials led by researchers from The University of Texas MD Anderson Cancer Center demonstrated early positive results from novel therapies targeting menin for the treatment of relapsed or refractory acute leukemias with specific genetic alterations. Results from the studies were shared today in oral presentations at the 2023 American Society of Hematology (ASH) Annual Meeting. More information on all ASH Annual Meeting content from MD Anderson can be found at MDAnderson.org/ASH. Menin inhibitor monotherapy ...

ASH: Targeted oral therapy reduced disease burden and improved symptoms for patients with rare blood disorder

ASH: Targeted oral therapy reduced disease burden and improved symptoms for patients with rare blood disorder
2023-12-09
SAN DIEGO ― The targeted therapy bezuclastinib was safe and rapidly reduced markers of disease burden while also improving symptoms for patients with a rare blood disorder called nonadvanced system mastocytosis, according to results of the Phase II SUMMIT trial reported by researchers at The University of Texas MD Anderson Cancer Center. The findings, presented today at the 2023 American Society of Hematology (ASH) Annual Meeting, demonstrate that all participants treated with bezuclastinib achieved at least a 50% reduction in markers of disease burden and 63% reported their disease symptoms eased within 12 weeks. That number increased to 78% after ...

New Sylvester cancer study provides insight into underlying gene mutations in myelodysplastic syndromes

2023-12-09
EMBARGOED UNTIL DECEMBER 9, 2023, AT 12:45 P.M. ET A new study from researchers with Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and collaborating organizations provides insight into the underlying mechanisms of gene mutations commonly seen in patients with myelodysplastic syndromes (MDS) and other myeloid neoplasms. Their findings, to be presented at ASH 2023, the American Society of Hematology’s annual meeting in Santa Diego, Dec. 9-12, could lead to development of more effective drug combinations ...

LAST 30 PRESS RELEASES:

Climate change is a health emergency too

Chronic stress accelerates colorectal cancer progression by disrupting the balance of gut microbiota, new study shows

Brazilian study identifies potential targets for treatment of visceral leishmaniasis

Using AI and iNaturalist, scientists build one of the highest resolution maps yet of California plants

Researchers identify signs tied to more severe cases of RSV

Mays Cancer Center radiation oncologist recognized as outstanding mentor to next generation leaders

Hitting the bull’s eye to target ‘undruggable’ diseases – researchers reveal new levels of detail in targeted protein degradation

SCAI publishes expert consensus statement on managing patients with ST-elevated myocardial infarction

Engineering perovskite materials at the atomic level paves way for new lasers, LEDs

Kessler Foundation 2024 Survey highlights key strategies for hiring and supporting workers with disabilities in the hospitality industry

Harnessing protons to treat cancer

Researchers identify neurodevelopmental symptoms that indicate genetic disorders

Electronic nudges to increase influenza vaccination in patients with chronic diseases

Plant stem cells: Better understanding the biological mechanism of growth control

Genomic study identifies human, animal hair in ‘man-eater’ lions’ teeth

These 19th century lions from Kenya ate humans, DNA collected from hairs in their teeth shows

A potential non-invasive stool test and novel therapy for endometriosis

Racial and ethnic disparities in age-specific all-cause mortality during the COVID-19 pandemic

Delft scientists discover how innate immunity envelops bacteria

Workforce diversity is key to advancing One Health

Genome Research publishes a special issue on innovations in computational biology

A quick and easy way to produce anode materials for sodium-ion batteries using microwaves

‘Inside-out’ galaxy growth observed in the early universe

Protein blocking bone development could hold clues for future osteoporosis treatment

A new method makes high-resolution imaging more accessible

Tiny magnetic discs offer remote brain stimulation without transgenes

Illuminating quantum magnets: Light unveils magnetic domains

Different types of teenage friendships critical to wellbeing as we age, scientists find

Hawaii distillery project wins funding from Scottish brewing and distilling award

Trinity researchers find ‘natural killer’ cells that live in the lung are ready for a sugar rush

[Press-News.org] Advanced MRI technology detects changes in the brain after COVID-19